We recently compiled a list of the 15 Best Biotech Stocks to Buy According to Billionaires. In this article, we are going to take a look at where Illumina, Inc.

Biomarker Research Services Market is estimated to be valued at USD 10.98 Bn in 2025 and is expected to reach USD 310.66 Bn by 2032, exhibiting a CAGR of 61%. Mr. Shah Coherent Market Insights Pvt.

The San Diego company also lowered its financial guidance for 2025 in response to China’s import restrictions.

As U.S. antitrust counsel to global companies, it is increasingly important to track major developments in the international ...

The move marks Beijing’s efforts to show strength as President Donald Trump targets China with consecutive rounds of trade tariffs. Bloomberg reported last week that Walmart asked some suppliers for ...

The Environmental Working Group's groundbreaking student leadership program, EWG+HS, has been chosen as one of a dozen social impact organizations to participate in the highly competitive Social ...

Gene-sequencing giant Illumina is laying off 96 employees from its San Diego headquarters, according to paperwork filed with the state. This workforce reduction comes at a time when Illumina is ...

Illumina, Inc. (NASDAQ ... We’re talking disease prediction, hyper-personalized marketing, and automated logistics that streamline everything. This isn’t a maybe – it’s an inevitability.

Credit: CI Photos via Shutterstock. Illumina has announced the development of an advanced spatial transcriptomics technology, with commercial availability expected in 2026. This next-generation ...

Trade war with China? Check. Cuts to scientific research? Check.

However, Illumina shares still appear moderately undervalued ... Gear advertisements and other marketing efforts towards your interests. To learn more about how we handle and protect your data ...